Literature DB >> 19544580

Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody.

Sandipan Sinha1, Lei Zhang, Shaofeng Duan, Todd D Williams, Josef Vlasak, Roxana Ionescu, Elizabeth M Topp.   

Abstract

The effects of secondary structure on asparagine (N) deamidation in a 22 amino acid sequence (369-GFYPSDIAVEWESNGQPENNYK-390) of the crystallizable (Fc) fragment of a human monoclonal antibody (Fc IgG1) were investigated using high-resolution ultra performance liquid chromatography with tandem mass spectrometry (UPLC/MS). Samples containing either the intact Fc IgG (approximately 50 kD) ("intact protein"), or corresponding synthetic peptides ("peptide") were stored in Tris buffer at 37 degrees C and pH 7.5 for up to forty days, then subjected to UPLC/MS analysis with high energy MS1 fragmentation. The peptide deamidated only at N(382) to form the isoaspartate (isoD(382)) and aspartate (D(382)) products in the ratio of approximately 4:1, with a half-life of approximately 3.4 days. The succinimide intermediate (Su(382)) was also detected; deamidation was not observed for the other two sites (N(387) and N(388)) in peptide samples. The intact protein showed a 30-fold slower overall deamidation half-life of approximately 108 days to produce the isoD(382) and D(387) products, together with minor amounts of D(382). Surprisingly, the D(382) and isoD(387) products were not detected in intact protein samples and, as in the peptide samples, deamidation was not detected at N(388). The results indicate that higher order structure influences both the rate of N-deamidation and the product distribution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544580      PMCID: PMC2776945          DOI: 10.1002/pro.173

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  33 in total

1.  Deamidation of human proteins.

Authors:  N E Robinson; A B Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Analysis of isoaspartate in a recombinant monoclonal antibody and its charge isoforms.

Authors:  Wei Zhang; Marta J Czupryn
Journal:  J Pharm Biomed Anal       Date:  2003-01-01       Impact factor: 3.935

3.  Degradation products analysis of an Fc fusion protein using LC/MS methods.

Authors:  Da Ren; Gayathri Ratnaswamy; Jill Beierle; Michael J Treuheit; David N Brems; Pavel V Bondarenko
Journal:  Int J Biol Macromol       Date:  2008-10-30       Impact factor: 6.953

4.  Deamidation in proteins: the crystal structure of bovine pancreatic ribonuclease with an isoaspartyl residue at position 67.

Authors:  S Capasso; A Di Donato; L Esposito; F Sica; G Sorrentino; L Vitagliano; A Zagari; L Mazzarella
Journal:  J Mol Biol       Date:  1996-04-05       Impact factor: 5.469

5.  Quantification of the isomerization of Asp residue in recombinant human alpha A-crystallin by reversed-phase HPLC.

Authors:  Yutaka Sadakane; Toshiaki Yamazaki; Kazuya Nakagomi; Toshifumi Akizawa; Noriko Fujii; Takenori Tanimura; Masaki Kaneda; Yasumaru Hatanaka
Journal:  J Pharm Biomed Anal       Date:  2003-01-15       Impact factor: 3.935

6.  Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide.

Authors:  K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

7.  Deamidation: Differentiation of aspartyl from isoaspartyl products in peptides by electron capture dissociation.

Authors:  Jason J Cournoyer; Jason L Pittman; Vera B Ivleva; Eric Fallows; Lucy Waskell; Catherine E Costello; Peter B O'Connor
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

8.  The aspartyl replacement of the active site histidine in histidine-containing protein, HPr, of the Escherichia coli Phosphoenolpyruvate:Sugar phosphotransferase system can accept and donate a phosphoryl group. Spontaneous dephosphorylation of acyl-phosphate autocatalyzes an internal cyclization.

Authors:  S Napper; L T Delbaere; E B Waygood
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

9.  Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.

Authors:  S Krapp; Y Mimura; R Jefferis; R Huber; P Sondermann
Journal:  J Mol Biol       Date:  2003-01-31       Impact factor: 5.469

10.  The influence of protein structure on the products emerging from succinimide hydrolysis.

Authors:  Lance Athmer; Jason Kindrachuk; Fawzy Georges; Scott Napper
Journal:  J Biol Chem       Date:  2002-06-14       Impact factor: 5.157

View more
  22 in total

1.  Human Immunoglobulin Heavy Gamma Chain Polymorphisms: Molecular Confirmation Of Proteomic Assessment.

Authors:  Magalie Dambrun; Célia Dechavanne; Alexandra Emmanuel; Florentin Aussenac; Marjorie Leduc; Chiara Giangrande; Joëlle Vinh; Jean-Michel Dugoujon; Marie-Paule Lefranc; François Guillonneau; Florence Migot-Nabias
Journal:  Mol Cell Proteomics       Date:  2017-03-06       Impact factor: 5.911

2.  Scientific considerations for generic synthetic salmon calcitonin nasal spray products.

Authors:  Sau L Lee; Lawrence X Yu; Bing Cai; Gibbes R Johnsons; Amy S Rosenberg; Barry W Cherney; Wei Guo; Andre S Raw
Journal:  AAPS J       Date:  2010-10-30       Impact factor: 4.009

Review 3.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

4.  Mass spectrometric distinction of in-source and in-solution pyroglutamate and succinimide in proteins: a case study on rhG-CSF.

Authors:  Mukesh Kumar; Amarnath Chatterjee; Anand P Khedkar; Mutyalasetty Kusumanchi; Laxmi Adhikary
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-03       Impact factor: 3.109

Review 5.  Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies.

Authors:  Yi Du; Alison Walsh; Robin Ehrick; Wei Xu; Kimberly May; Hongcheng Liu
Journal:  MAbs       Date:  2012-07-23       Impact factor: 5.857

6.  Mass Spectrometry Based Mechanistic Insights into Formation of Tris Conjugates: Implications on Protein Biopharmaceutics.

Authors:  Pradeep G Kabadi; Praveen Kallamvalliillam Sankaran; Dinesh V Palanivelu; Laxmi Adhikary; Anand Khedkar; Amarnath Chatterjee
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-03       Impact factor: 3.109

Review 7.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 8.  Forced degradation of recombinant monoclonal antibodies: A practical guide.

Authors:  Christine Nowak; Jason K Cheung; Shara M Dellatore; Amit Katiyar; Ram Bhat; Joanne Sun; Gomathinayagam Ponniah; Alyssa Neill; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

9.  Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.

Authors:  Alavattam Sreedhara; Armando Cordoba; Qing Zhu; Jeanne Kwong; Jun Liu
Journal:  Pharm Res       Date:  2011-08-02       Impact factor: 4.200

10.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.